Ht-Logo-gigapixel-icon
Ht-Logo-gigapixel-icon
Friday, March 24, 2023
Canada’s Politics and Government News Source Since 1989
Latest Paper
Friday, March 24, 2023 | Latest Paper
Subscribe Now

TRENDING:

Jason Field

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

  • When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of
Opinion | BY JASON FIELD | June 30, 2022
The changes add several lower-priced countries to the basket of those to which Canada’s prices must be compared to determine the maximum permissible price, while removing the U.S. and Switzerland from the mix to lower the price ceiling. Unsplash photograph by Laurynas Mereckas

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

Opinion | BY JASON FIELD | June 30, 2022
  • When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

Opinion | BY JASON FIELD | June 30, 2022
  • When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of
The changes add several lower-priced countries to the basket of those to which Canada’s prices must be compared to determine the maximum permissible price, while removing the U.S. and Switzerland from the mix to lower the price ceiling. Unsplash photograph by Laurynas Mereckas

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

  • When reports of a new respiratory disease first emerged in January 2020, it was difficult to imagine the level of social and economic disruption
Opinion | BY JASON FIELD | July 8, 2021
Periods of crisis create opportunities to re-evaluate policies, adapt practices, and consider new approaches. COVID-19 has shown us we can be very nimble when necessary, including by compressing processes into weeks or days what would normally have taken months or years. The Hill Times photograph by Andrew Meade

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

Opinion | BY JASON FIELD | July 8, 2021
  • When reports of a new respiratory disease first emerged in January 2020, it was difficult to imagine the level of social and economic disruption

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

Opinion | BY JASON FIELD | July 8, 2021
  • When reports of a new respiratory disease first emerged in January 2020, it was difficult to imagine the level of social and economic disruption
Periods of crisis create opportunities to re-evaluate policies, adapt practices, and consider new approaches. COVID-19 has shown us we can be very nimble when necessary, including by compressing processes into weeks or days what would normally have taken months or years. The Hill Times photograph by Andrew Meade

Cheaper isn’t always better, and prescription drugs are no exception

  • Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.
Opinion | BY JASON FIELD | December 15, 2017
The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade

Cheaper isn’t always better, and prescription drugs are no exception

Opinion | BY JASON FIELD | December 15, 2017
  • Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.

Cheaper isn’t always better, and prescription drugs are no exception

Opinion | BY JASON FIELD | December 15, 2017
  • Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.
The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu